Contacts, documents and full notice history are available with a subscription.
Award Notice NONE 2 notices 1 document

Q301 - Thyro Seq v3 Genomic Classifier (GC) Testing 36C25026Q0100

Solicitation 36C25026Q0100 Copied Notice ID 59b46215eef440f19a052d08ad2a1d3c Copied VETERANS AFFAIRS, DEPARTMENT OF — 250-NETWORK CONTRACT OFFICE 10 (36C250)
SAM.gov
Posted
Dec 23, 2025
Deadline
No deadline
Set-aside
NONE
NAICS
621511
PSC
Q301

Summary

AI-generated · Nov 05, 2025

Molecular diagnostic testing services using the ThyroSeq v3 Genomic Classifier (GC) are required for the VA Northeast Ohio Healthcare System, Pathology and Laboratory Medicine Service. The ThyroSeq v3 GC is a proprietary assay developed, validated, and performed exclusively by CBL Path, which is the sole source provider in the United States; as such, the government intends to award a sole-source contract to CYTOPATH BIOPSY LAB INC under FAR 6.302-1. This is not a competitive solicitation, but the agency may consider capability statements from other responsible sources per FAR 5.207 to determine if competition would be advantageous.

Not a solicitation package will be issued. Responses should demonstrate clear ability to meet the requirement and why competition would be advantageous; any submission should be emailed to the designated VA contact by the stated deadline.

Notice of Intent to Sole-Source Requirement The Department of Veterans Affairs, Network Contracting Office (NCO) 10, intends to negotiate a sole source contract under Simplified Acquisition Procedures and the authority of FAR 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. The associated NAICS code for this is 621511, Size Standard is $41.5 Million. The Product Service Code (PSC) is Q301. The sole-source contract will be awarded to: CYTOPATH BIOPSY LAB INC UEI: KC5VWAGMNLT6 Description of equipment requirements: The VA Northeast Ohio Healthcare System (VANEOHS), Pathology and Laboratory Medicine Service (PALMS), requires molecular diagnostic testing services using the ThyroSeq v3 Genomic Classifier (GC). The ThyroSeq v3 Genomic Classifier is a proprietary molecular assay exclusively developed, validated, and performed by CBL PATH, which is the sole source provider of this test in the United States. It is the Government's belief that only the proposed candidate possesses the required capabilities to successfully meet this requirement. It is the Government's intention to solicit and negotiate with only this source. This notice of intent is not a request for competitive proposals. IAW FAR 5.207 all responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency. This is not a solicitation or request for offers. No solicitation package is available. Any response to this notice must show clear and convincing evidence that demonstrates the ability to comply with the requirement and that competition would be advantageous to the Government. The Government will not pay for information submitted. A determination not to compete based on responses to this notice is solely within the discretion of the Government. All responses to this intent to sole source must be emailed to Thomas Bellamy @ thomas.bellamy@va.gov by 3:00 p.m. EST November 12th, 2025.

From Special Notice posted on Nov 04, 2025

The Department of Veterans Affairs, Network Contracting Office 10, made an award for a one (1) year firm fixed price (FFP) contract with Cytopath Biopsy Lab, INC, 760 Westchester Ave., Rye Brook, NY 10573 to provide ThyroSeq V3 Genomic Classifier testing services for the Louis Stokes VA Medical Center, Pathology & Laboratory Services (PALMS), 10701 East BLVD., Cleveland, OH 44106. The point of contact is Thomas Bellamy, Contracting Officer, Network Contracting Office 10 - Thomas.Bellamy@va.gov.

From Award Notice posted on Dec 23, 2025

Notice history

2
  1. Special Notice Posted Nov 04, 2025 View
  2. Award Notice LATEST Posted Dec 23, 2025

Details

Solicitation number 36C25026Q0100
Notice ID 59b46215eef440f19a052d08ad2a1d3c
Award number 36C25026P0252
Notice type Award Notice
Product / Service (PSC) Q301
NAICS 621511
Set-aside No Set aside used
Place of performance Cleveland, Ohio
Archive date Jan 07, 2026

Award Information

Awardee
1
Total Awarded
$146,250.00
Award Date
Dec 23, 2025

Award Notices

Q301 - Thyro Seq v3 Genomic Classifier (GC) Testing View Notice

Posted: Dec 23, 2025

The Department of Veterans Affairs, Network Contracting Office 10, made an award for a one (1) year firm fixed price (FFP) contract with Cytopath Biopsy Lab, INC, 760 Westchester Ave., Rye Brook, NY 10573 to provide ThyroSeq V3 Genomic Classifier testing services for the Louis Stokes VA Medical Cent...

Awardees

Company Name UEI CAGE Code Location
CYTOPATH BIOPSY LAB INC KC5VWAGMNLT6 7ASS1 Rye Brook, NY

Documents

1
View on SAM.gov

Contacts

primary
Thomas Bellamy

Email

Phone

Agency

VETERANS AFFAIRS, DEPARTMENT OF
VETERANS AFFAIRS, DEPARTMENT OF
250-NETWORK CONTRACT OFFICE 10 (36C250)

Place of Performance

Cleveland, Ohio 44106
USA

Dates

Posted Dec 23, 2025 7 months ago
Last Updated Aug 06, 2026 2 days ago
Awarded Dec 23, 2025 7 months ago